Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals Revenue

Intercept Pharmaceuticals had revenue of $317.68M in the twelve months ending September 30, 2023, with 14.64% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $88.79M with 14.44% year-over-year growth. In the year 2022, Intercept Pharmaceuticals had annual revenue of $285.71M with 9.57% growth.

• Revenue (ttm): $317.68M
• Revenue Growth: +14.64%
• P/S Ratio: 2.50
• Revenue / Employee: $931,625
• Employees: 341
• Market Cap: 794.36M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	285.71M	24.96M	9.57%
Dec 31, 2021	260.75M	26.78M	11.45%
Dec 31, 2020	233.97M	-18.03M	-7.16%
Dec 31, 2019	252.00M	72.20M	40.15%
Dec 31, 2018	179.80M	48.85M	37.30%
Dec 31, 2017	130.96M	106.01M	424.85%
Dec 31, 2016	24.95M	22.17M	796.87%
Dec 31, 2015	2.78M	1.04M	59.70%
Dec 31, 2014	1.74M	120.00K	7.40%
Dec 31, 2013	1.62M	-824.11K	-33.69%
Dec 31, 2012	2.45M	640.98K	35.51%
Dec 31, 2011	1.81M	-	-
Dec 31, 2010	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.